144 related articles for article (PubMed ID: 23510980)
1. The economics of biobanking and pharmacogenetics databasing: the case of an adaptive platform on breast cancer.
Huttin CC; Liebman MN
Technol Health Care; 2013; 21(2):183-90. PubMed ID: 23510980
[TBL] [Abstract][Full Text] [Related]
2. A contribution for cost models in biobanking.
Huttin C; Stubbs A
Technol Health Care; 2016; 24(1):93-8. PubMed ID: 26757438
[TBL] [Abstract][Full Text] [Related]
3. The biobanking research infrastructure BBMRI_CZ: a critical tool to enhance translational cancer research.
Holub P; Greplova K; Knoflickova D; Nenutil R; Valik D
Klin Onkol; 2012; 25 Suppl 2():2S78-81. PubMed ID: 23581021
[TBL] [Abstract][Full Text] [Related]
4. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
[TBL] [Abstract][Full Text] [Related]
5. Sustainability in Biobanking: Model of Biobank Graz.
Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
[TBL] [Abstract][Full Text] [Related]
6. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
[TBL] [Abstract][Full Text] [Related]
7. Translational research in pediatrics: tissue sampling and biobanking.
Brisson AR; Matsui D; Rieder MJ; Fraser DD
Pediatrics; 2012 Jan; 129(1):153-62. PubMed ID: 22144705
[TBL] [Abstract][Full Text] [Related]
8. An empirical survey on biobanking of human genetic material and data in six EU countries.
Hirtzlin I; Dubreuil C; Préaubert N; Duchier J; Jansen B; Simon J; Lobato De Faria P; Perez-Lezaun A; Visser B; Williams GD; Cambon-Thomsen A;
Eur J Hum Genet; 2003 Jun; 11(6):475-88. PubMed ID: 12774042
[TBL] [Abstract][Full Text] [Related]
9. Integrating clinical and biological information in a shanghai biobank: an introduction to the sample repository and information sharing platform project.
Cui W; Zheng P; Yang J; Zhao R; Gao J; Yu G
Biopreserv Biobank; 2015 Feb; 13(1):37-42. PubMed ID: 25686046
[TBL] [Abstract][Full Text] [Related]
10. Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research.
Rogers J; Carolin T; Vaught J; Compton C
J Natl Cancer Inst Monogr; 2011; 2011(42):32-8. PubMed ID: 21672893
[TBL] [Abstract][Full Text] [Related]
11. TuBaFrost 1: Uniting local frozen tumour banks into a European network: an overview.
Riegman PH; Dinjens WN; Oomen MH; Spatz A; Ratcliffe C; Knox K; Mager R; Kerr D; Pezzella F; van Damme B; van de Vijver M; van Boven H; Morente MM; Alonso S; Kerjaschki D; Pammer J; Lopez-Guerrero JA; Llombart Bosch A; Carbone A; Gloghini A; Teodorovic I; Isabelle M; Jaminé D; Passioukov A; Lejeune S; Therasse P; van Veen EB; Lam KH; Oosterhuis JW
Eur J Cancer; 2006 Nov; 42(16):2678-83. PubMed ID: 17027254
[TBL] [Abstract][Full Text] [Related]
12. The human side of cancer biobanking.
Gaffney EF; Madden D; Thomas GA
Methods Mol Biol; 2012; 823():59-77. PubMed ID: 22081339
[TBL] [Abstract][Full Text] [Related]
13. Business Planning in Biobanking: How to Implement a Tool for Sustainability.
Ciaburri M; Napolitano M; Bravo E
Biopreserv Biobank; 2017 Feb; 15(1):46-56. PubMed ID: 27898226
[TBL] [Abstract][Full Text] [Related]
14. Biobank Finances: A Socio-Economic Analysis and Review.
Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
[TBL] [Abstract][Full Text] [Related]
15. Addressing the Challenge of Financial Sustainability in Biobanking.
Campos AH; Schreeder M; Parry-Jones A; Abdelhafiz AS; Larson D; Pruetz B; Geddes T; Salman A; Lazaris A
Biopreserv Biobank; 2015 Dec; 13(6):387-95. PubMed ID: 26697907
[No Abstract] [Full Text] [Related]
16. Cost model for biobanks.
Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
[TBL] [Abstract][Full Text] [Related]
17. [Biobanking in Israel: a new platform for collaboration].
Meir K; Cohen Y
Harefuah; 2013 Jun; 152(6):317-8, 370. PubMed ID: 23885460
[No Abstract] [Full Text] [Related]
18. Taiwan Biobank: a project aiming to aid Taiwan's transition into a biomedical island.
Fan CT; Lin JC; Lee CH
Pharmacogenomics; 2008 Feb; 9(2):235-46. PubMed ID: 18370851
[TBL] [Abstract][Full Text] [Related]
19. Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis.
Mendy M; Caboux E; Sylla BS; Dillner J; Chinquee J; Wild C;
Pathobiology; 2014; 81(5-6):252-260. PubMed ID: 25792214
[TBL] [Abstract][Full Text] [Related]
20. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
Vaught J; Rogers J; Carolin T; Compton C
J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
